EUVIMEDEUVIMED entdecken
Crossref

Novel compound NHWD-870 suppresses melanoma proliferation by inducing cell cycle arrest and apoptosis

Yingying Liu, Hongyin Sun, Mingzhu Yin, Yadong Xue, Rui Hu

Eurasian Journal of Medicine and Oncology · 31.03.2026 · 10 (5) · 025010554

DOI: 10.36922/ejmo025010554 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Eurasian Journal of Medicine and Oncology, online erschienen am 31.03.2026. Verfasst von Yingying Liu und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Malignant melanoma is the most aggressive form of skin cancer worldwide. Although various novel therapies, including targeted therapies, immunotherapies, and epigenetic therapies, have been developed in recent decades to provide new treatment options, most patients with melanoma either respond poorly or develop resistance quickly. Thus, new therapeutic options are urgently needed. Bromodomain and extra-terminal domain (BET) inhibition has emerged as a potential therapeutic strategy in cancer treatment.

Objectives

We aimed to study the effects of NHWD-870, a novel BET inhibitor analogue of BMS-986158, on melanoma proliferation.

Methods

We examined the effects of BMS-986158 and NHWD-870 on tumor proliferation in vitro and in vivo using the Cell Counting Kit-8 assay, Ki67-positive cell analysis, colony formation assay, and a xenograft mouse model. Flow cytometry and Western blotting were performed to investigate the effects of NHWD-870 on melanoma cell cycle and apoptosis.

Results

We found that NHWD-870 exhibited improved ability to suppress melanoma cell proliferation both in vitro and in vivo compared to BMS-986158. Mechanistically, NHWD-870 treatment induced G2/M cell cycle arrest and apoptosis, accompanied by decreased cyclin B1 levels.

Conclusion

Our results suggest that NHWD-870 exhibits effective antineoplastic potency. It effectively inhibits melanoma progression, demonstrating greater efficacy than BMS-986158. These findings support further development of NHWD-870 as a potential new therapeutic candidate for melanoma treatment.

Zitieren

APA

Liu, Y., Sun, H., Yin, M., Xue, Y., & Hu, R. (2026). Novel compound NHWD-870 suppresses melanoma proliferation by inducing cell cycle arrest and apoptosis. Eurasian Journal of Medicine and Oncology, 10(5), 025010554. https://doi.org/10.36922/ejmo025010554

Vancouver

Liu Y, Sun H, Yin M, Xue Y, Hu R. Novel compound NHWD-870 suppresses melanoma proliferation by inducing cell cycle arrest and apoptosis. Eurasian Journal of Medicine and Oncology. 2026;10(5):025010554. doi:10.36922/ejmo025010554

BibTeX
@article{Liu2026,
  author = {Liu, Yingying and Sun, Hongyin and Yin, Mingzhu and Xue, Yadong and Hu, Rui},
  title = {Novel compound NHWD-870 suppresses melanoma proliferation by inducing cell cycle arrest and apoptosis},
  journal = {Eurasian Journal of Medicine and Oncology},
  year = {2026},
  volume = {10},
  number = {5},
  pages = {025010554},
  doi = {10.36922/ejmo025010554}
}
Kostenlos starten →